Clovis Follows 2011 IPO with $75M Public Offering
By Marie Powers
Thursday, April 5, 2012
Clovis Oncology Inc. wasted little time padding its coffers after an initial public offering (IPO) in November 2011 put the small biopharma in a category of one: Clovis was the only biotech to price a 2011 IPO within its initial range.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.